ExpreS2ion to participate in upcoming events
Hørsholm, Denmark, 27 March 2023 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") will participate and hold presentations at key industry and investor events in the coming month. These include Swiss Nordic Bio (30 March), a Rights Issue Q&A (31 March), the AACR Annual Meeting (14-19 April) and the Økonomisk Ugebrev Life Science Investor Conference (19 April).By attending relevant industry and investor events, the company aims to increase the awareness of the ExpreS[2] technology platform and its exciting development pipeline, including the novel ES2B-